Drp1 inhibitor treatment restores the mitochondrial dynamics balance in the AD model and alleviates mitochondrial dysfunction associated with excessive β-amyloid–induced autophagy (73, 74). The gene discussed is DNM1L; the disease is Alzheimer disease.